Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA, Orexigen Discussing CV Risk Study For Weight-Loss Drug Contrave
03 Dec 2010
•
By
The Pink Sheet Daily
Timing of the study to be discussed at Dec. 7 advisory committee meeting.
More from Archive
More from Pink Sheet